Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Stellar Biotechnologies, Inc V.KLH

Sector: Healthcare | Sub-Sector: Biotechnology

Stellar Biotechnologies, Inc. is in the production of KLH, an immuno-stimulatory protein used in vaccines & other biomedical products. Its customers and co-research partners include multi-national pharmaceutical companies and among others.
Price: $1.91 | Change: +$0.03 | %Change: +1.60%
Volume: 307,899 | Day High/Low: 1.93/1.74 | 52 Week High/Low: 2.55/0.65


Last Traded: September 17, 2014 11:59 Transaction Volume: 307,899
Open: $1.91 Previous Close: $1.88
Bid: $1.87 Ask: $1.90
Bid Size: 1,000 Ask Size: 2,800
Market Cap: $149.8m Shares Out: 78.4m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts


    0 stars

    Highly Recommend this site for anyone interested in Stella Biotech.  Lot's of info on trial studies and lots of other info.  I do not...

    3 stars

  • The take on this stock

    0 stars

    Macroaxis applies Modern Portfolio Theory, see this writeup at Barron's for details. It has many scenarios that can be applied to a stock...

    2 stars

  • RE:RE:KLH from a public Blog

    0 stars

    Thanks, A year late and a $100 short, 'eh! It showed up on a google search using past week as time period and I missed the date. There is...

    3 stars

  • RE:KLH from a public Blog

    0 stars

    The blog is from Sept 2013. Probably the same conference as this year.

    3 stars

  • KLH from a public Blog

    0 stars

    Aftermath: Stellar Biotech Conference Presentation. Much ado about little. Posted on  September 9, 2013  by Jim Skelton,...

    3 stars